Published in Clin Exp Immunol on April 01, 2001
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells. Clin Exp Immunol (2014) 0.78
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today (1990) 2.12
Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods (1987) 1.85
Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol (1993) 1.73
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem (1995) 1.49
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant (1996) 1.41
Growing human B lymphocytes in the CD40 system. Nature (1991) 1.37
Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur J Immunol (1987) 1.26
Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol (1995) 1.11
Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol (1998) 1.04
Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation (1998) 1.00
Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity. Transplantation (1993) 0.99
Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol (1999) 0.99
Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol (1997) 0.95
Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation (1987) 0.95
Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation (1996) 0.89
The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens. Clin Exp Immunol (1993) 0.88
The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87
Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur J Immunol (1992) 0.83
The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation (1995) 0.82
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. Transplantation (1992) 0.80
Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study. Hum Immunol (1995) 0.80
Quantitative analysis of precursors frequency of rheumatoid factor (RF) producing human B cells. Scand J Rheumatol Suppl (1988) 0.80
Clinical relevance of cytotoxic T-cell precursor (p-CTL) frequencies in allograft recipients. Transplant Proc (1990) 0.79
The flow cytometric detection of alloantibodies in screening for renal transplantation. Transpl Int (1995) 0.79
The alloantibody response in the allogeneically pregnant rat. I. The primary and secondary responses and detection of Ir gene control. J Immunol (1982) 0.78
ELISA anti-HLA antibody screening identifies non-complement-fixing antibodies responsible for acute graft rejection. A case report. Eur J Immunogenet (1996) 0.77
A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. Bone Marrow Transplant (1996) 0.77
Limiting dilution analysis of Epstein-Barr virus infectable B cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus and systemic lupus erythematosus. J Autoimmun (1993) 0.77
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood (1995) 1.58
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro. Transplantation (2001) 1.46
On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol (1991) 1.44
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Renal allograft rejection and antibodies to epithelial cells. Lancet (1992) 1.42
Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation (2001) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation (2001) 1.37
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol (1997) 1.36
Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum (1991) 1.36
Carboxyfluorescein fluorochromasia assays. I. Non-radioactively labeled cell mediated lympholysis. J Immunol Methods (1980) 1.33
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics (1998) 1.25
Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol (1985) 1.25
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2000) 1.20
Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy. J Neurol Sci (1984) 1.19
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. Cancer Res (1996) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol (2001) 1.15
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol (1999) 1.11
HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol (1996) 1.11
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol (2000) 1.07
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation (1996) 1.07
HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications. Proc Natl Acad Sci U S A (1991) 1.07
Interaction of penicillin with HLA-A and -B antigens. Hum Immunol (1982) 1.01
Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol (1999) 1.01
T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J Immunol (1991) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis (1998) 1.00
Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation (1998) 1.00
Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol (1986) 1.00
Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. Transplant Proc (1981) 0.98
Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol (2001) 0.98
Demonstration of granulocyte, monocyte, and endothelial cell antigens by double fluorochromatic microcytotoxicity testing. Transplant Proc (1980) 0.98
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett (1981) 0.97
In the queue for a cadaver donor kidney transplant: new rules and concepts in the Eurotransplant International Foundation. Nephrol Dial Transplant (2000) 0.97
TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies. Hum Immunol (1986) 0.97
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens (1998) 0.96
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol (1997) 0.95
The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol (2001) 0.94
Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med (1979) 0.94
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet (1996) 0.93
Characterization of the ABO blood group genes in macaques: evidence for convergent evolution. Tissue Antigens (1998) 0.93
Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol (1993) 0.93
Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation (2000) 0.92
Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients. Am J Transplant (2013) 0.92
Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia (2004) 0.92
Felty syndrome: autoimmune neutropenia or immune-complex-mediated disease? Rheumatol Int (1985) 0.92
New facts on HLA genetics: are they relevant in bone marrow transplantation? Semin Hematol (1984) 0.92
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation (1990) 0.92
Validation of haplotype frequency estimation methods. Hum Immunol (1998) 0.91
Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials (2002) 0.91
Nomenclature for factors of the HLA System, 1998. Hum Immunol (1999) 0.91
Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol (2013) 0.91
Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol (1981) 0.90
HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology (1987) 0.90
Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang (1988) 0.89
A monoclonal antibody detecting an HLA-DQwl-related determinant. Tissue Antigens (1985) 0.89
Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation (1996) 0.89
HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens (1998) 0.89
H-2 linked immune response to murine experimental Schistosoma mansoni infections. J Immunogenet (1979) 0.88
Nomenclature for factors of the HLA system, 2000. Hum Immunol (2001) 0.88
The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87
The interaction between gamma-type endorphins and HLA class I antigens. Hum Immunol (1986) 0.87
Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals. Immunogenetics (1986) 0.87
Automated reading of HLA-A,B,C typing and screening. The propidium iodide (PI) method. Hum Immunol (1982) 0.87
No evidence of an influence of the noninherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals. Transplantation (1995) 0.87
Do noninherited maternal antigens (NIMA) enhance renal graft survival? Transpl Int (1998) 0.87
Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol (1992) 0.87
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics (1998) 0.87
A human monoclonal antibody against HLA-Cw1 and a human monoclonal antibody against an HLA-A locus determinant derived from a single uniparous female. Tissue Antigens (1998) 0.86
HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigens (1996) 0.86
Omeprazole-associated agranulocytosis. Eur J Haematol (1995) 0.86
The detection of non-HLA antibodies and their possible role in bone marrow graft rejection. Transplant Proc (1979) 0.86
NE1: a new neutrophil specific antigen. Tissue Antigens (1979) 0.86